$465 Million is the total value of 5AM Venture Management, LLC's 9 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
APRE | New | Aprea Therapeutics, Inc. | $130,908,000 | – | 2,852,654 | +100.0% | 28.17% | – |
FIXX | New | Homology Medicines, Inc. | $114,594,000 | – | 5,535,919 | +100.0% | 24.66% | – |
CRNX | New | Crinetics Pharmaceuticals, Inc. | $59,270,000 | – | 2,362,286 | +100.0% | 12.75% | – |
ARVN | New | Arvinas, Inc. | $56,639,000 | – | 1,378,423 | +100.0% | 12.19% | – |
CABA | New | Cabaletta Bio, Inc. | $51,260,000 | – | 3,669,263 | +100.0% | 11.03% | – |
IDYA | New | IDEAYA Biosciences, Inc. | $25,973,000 | – | 3,463,066 | +100.0% | 5.59% | – |
SCPH | New | scPharmaceuticals Inc. | $18,414,000 | – | 3,253,440 | +100.0% | 3.96% | – |
CDTX | New | Cidara Therapeutics, Inc. | $7,705,000 | – | 2,006,511 | +100.0% | 1.66% | – |
New | Viveve Medical, Inc. | $10,000 | – | 8,078 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-05
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
HOMOLOGY MEDICINES INC | 16 | Q3 2023 | 26.6% |
ARVINAS INC | 16 | Q3 2023 | 14.3% |
Crinetics Pharmaceuticals, Inc. | 16 | Q3 2023 | 12.8% |
SCPHARMACEUTICALS INC | 16 | Q3 2023 | 7.5% |
CIDARA THERAPEUTICS INC | 16 | Q3 2023 | 1.7% |
IDEAYA BIOSCIENCES INC | 14 | Q1 2023 | 11.4% |
VOR BIOPHARMA INC | 11 | Q3 2023 | 51.9% |
CABALETTA BIO INC | 11 | Q2 2022 | 14.2% |
AKOUOS INC | 10 | Q3 2022 | 27.7% |
IMPEL PHARMACEUTICALS INC | 10 | Q3 2023 | 7.1% |
View 5AM Venture Management, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-03 |
13F-HR | 2021-11-15 |
View 5AM Venture Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.